Universal Health (UHS) Stock Forecast & Price Target

Compare

564 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

UHS Analyst Ratings

Moderate Buy

3 Buy

2 Hold

0 Sell

Based on 5 analysts giving stock ratings to

Universal

Health

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

UHS Stock 12 Month Forecast

Average Price Target

$252.20

▲(9.66% Upside)

Based on 5 Wall Street analysts offering 12 month price targets for Universal Health in the last 3 months. The average price target is $252.20 with a high forecast of $274.00 and a low forecast of $235.00. The average price target represents a 9.66% change from the last price of $229.98.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"161":"$161","218":"$218","275":"$275","189.5":"$189.5","246.5":"$246.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":274,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$274.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":252.2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$252.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":235,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$235.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[161,189.5,218,246.5,275],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,201.86,207.4092307692308,212.95846153846156,218.5076923076923,224.05692307692308,229.60615384615386,235.15538461538463,240.7046153846154,246.25384615384615,251.80307692307693,257.3523076923077,262.90153846153845,268.45076923076925,{"y":274,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,201.86,205.7323076923077,209.60461538461539,213.47692307692307,217.3492307692308,221.22153846153847,225.09384615384616,228.96615384615384,232.83846153846153,236.71076923076924,240.58307692307693,244.45538461538462,248.3276923076923,{"y":252.2,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,201.86,204.4092307692308,206.95846153846156,209.5076923076923,212.05692307692308,214.60615384615386,217.15538461538463,219.70461538461538,222.25384615384615,224.80307692307693,227.3523076923077,229.90153846153845,232.45076923076923,{"y":235,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":187.785,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":174.53,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":187.252,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":174.111,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":187.019,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":188.576,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":162.666,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":181.231,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":203.342,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":216.831,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":239.43,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":218.02,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":201.86,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$274.00

Average Price Target$252.20

Lowest Price Target$235.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Jason Cassorla

Guggenheim

$274

Buy

19.14%

Upside

Reiterated

02/23/26

Guggenheim Keeps Their Buy Rating on Universal Health (UHS)

Ben Hendrix

RBC Capital

$231→$245

Hold

6.53%

Upside

Reiterated

02/17/26

RBC Capital Reaffirms Their Hold Rating on Universal Health (UHS)

Stephen Baxter

Wells Fargo

$235

Hold

2.18%

Upside

Reiterated

01/28/26

Analysts Offer Insights on Healthcare Companies: Corvus Pharmaceuticals (NASDAQ: CRVS), Elevance Health (NYSE: ELV) and Universal Health (NYSE: UHS)

Andrew Mok CFA

Barclays

$263→$262

Buy

13.92%

Upside

Reiterated

01/22/26

Barclays Keeps Their Buy Rating on Universal Health (UHS)

Ryan Langston

TD Cowen

$251→$245

Buy

6.53%

Upside

Reiterated

01/07/26

TD Cowen Remains a Buy on Universal Health (UHS)

Benjamin Rossi

J.P. Morgan

$240

Hold

4.36%

Upside

Reiterated

11/18/25

Universal Health (UHS) Receives a Hold from J.P. Morgan

John Ransom

Raymond James

$270

Buy

17.40%

Upside

Upgraded

11/03/25

Universal Health upgraded to Outperform from Market Perform at Raymond JamesUniversal Health upgraded to Outperform from Market Perform at Raymond James

Ann Hynes

Mizuho Securities

$242→$267

Buy

16.10%

Upside

Reiterated

11/03/25

Universal Health price target raised to $267 from $242 at MizuhoUniversal Health price target raised to $267 from $242 at Mizuho

A.J. Rice

UBS

$280→$302

Buy

31.32%

Upside

Reiterated

10/29/25

Universal Health price target raised to $302 from $280 at UBSUniversal Health price target raised to $302 from $280 at UBS

Craig Hettenbach

Morgan Stanley

$200→$233

Hold

1.31%

Upside

Reiterated

10/29/25

Universal Health's Mixed Q3 Performance and Stable Outlook Justify Hold Rating

Kevin Fischbeck

Bank of America Securities

$165→$190

Sell

-17.38%

Downside

Reiterated

10/28/25

Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (NASDAQ: BMRN) and Universal Health (NYSE: UHS)

Matthew Gillmor CFA

KeyBanc

―

Hold

―

Reiterated

10/28/25

KeyBanc Remains a Hold on Universal Health (UHS)

Sarah James

Cantor Fitzgerald

$227

Hold

-1.30%

Downside

Reiterated

10/27/25

Cantor Fitzgerald Reaffirms Their Hold Rating on Universal Health (UHS)

Whit Mayo

Leerink Partners

$276

Buy

20.01%

Upside

Reiterated

10/22/25

Leerink Partners Keeps Their Buy Rating on Universal Health (UHS)

Scott Fidel

Goldman Sachs

$180→$219

Hold

-4.77%

Downside

Reiterated

10/15/25

Goldman Sachs Sticks to Their Hold Rating for Universal Health (UHS)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Jason Cassorla

Guggenheim

$274

Buy

19.14%

Upside

Reiterated

02/23/26

Guggenheim Keeps Their Buy Rating on Universal Health (UHS)

Ben Hendrix

RBC Capital

$231→$245

Hold

6.53%

Upside

Reiterated

02/17/26

RBC Capital Reaffirms Their Hold Rating on Universal Health (UHS)

Stephen Baxter

Wells Fargo

$235

Hold

2.18%

Upside

Reiterated

01/28/26

Analysts Offer Insights on Healthcare Companies: Corvus Pharmaceuticals (NASDAQ: CRVS), Elevance Health (NYSE: ELV) and Universal Health (NYSE: UHS)

Andrew Mok CFA

Barclays

$263→$262

Buy

13.92%

Upside

Reiterated

01/22/26

Barclays Keeps Their Buy Rating on Universal Health (UHS)

Ryan Langston

TD Cowen

$251→$245

Buy

6.53%

Upside

Reiterated

01/07/26

TD Cowen Remains a Buy on Universal Health (UHS)

Benjamin Rossi

J.P. Morgan

$240

Hold

4.36%

Upside

Reiterated

11/18/25

Universal Health (UHS) Receives a Hold from J.P. Morgan

John Ransom

Raymond James

$270

Buy

17.40%

Upside

Upgraded

11/03/25

Universal Health upgraded to Outperform from Market Perform at Raymond JamesUniversal Health upgraded to Outperform from Market Perform at Raymond James

Ann Hynes

Mizuho Securities

$242→$267

Buy

16.10%

Upside

Reiterated

11/03/25

Universal Health price target raised to $267 from $242 at MizuhoUniversal Health price target raised to $267 from $242 at Mizuho

A.J. Rice

UBS

$280→$302

Buy

31.32%

Upside

Reiterated

10/29/25

Universal Health price target raised to $302 from $280 at UBSUniversal Health price target raised to $302 from $280 at UBS

Craig Hettenbach

Morgan Stanley

$200→$233

Hold

1.31%

Upside

Reiterated

10/29/25

Universal Health's Mixed Q3 Performance and Stable Outlook Justify Hold Rating

Kevin Fischbeck

Bank of America Securities

$165→$190

Sell

-17.38%

Downside

Reiterated

10/28/25

Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (NASDAQ: BMRN) and Universal Health (NYSE: UHS)

Matthew Gillmor CFA

KeyBanc

―

Hold

―

Reiterated

10/28/25

KeyBanc Remains a Hold on Universal Health (UHS)

Sarah James

Cantor Fitzgerald

$227

Hold

-1.30%

Downside

Reiterated

10/27/25

Cantor Fitzgerald Reaffirms Their Hold Rating on Universal Health (UHS)

Whit Mayo

Leerink Partners

$276

Buy

20.01%

Upside

Reiterated

10/22/25

Leerink Partners Keeps Their Buy Rating on Universal Health (UHS)

Scott Fidel

Goldman Sachs

$180→$219

Hold

-4.77%

Downside

Reiterated

10/15/25

Goldman Sachs Sticks to Their Hold Rating for Universal Health (UHS)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Universal Health

3 Months

xxx

Success Rate

13/17 ratings generated profit

Average Return

+3.79%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 76.47% of your transactions generating a profit, with an average return of +3.79% per trade.

1 Year

Jason CassorlaGuggenheim

Success Rate

9/12 ratings generated profit

Average Return

+18.71%

reiterated a buy rating 3 days ago

Copying Jason Cassorla's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +18.71% per trade.

2 Years

xxx

Success Rate

10/12 ratings generated profit

Average Return

+31.94%

reiterated a xxx

rating 3 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 83.33% of your transactions generating a profit, with an average return of +31.94% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

UHS Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, UHS has received 16 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. UHS average Analyst price target in the past 3 months is 252.20.

Each month's total comprises the sum of three months' worth of ratings.

UHS Financial Forecast

UHS Earnings Forecast

Currently, no earnings data available.

UHS Sales Forecast

Currently, no sales data available.

UHS Stock Forecast FAQ

What is UHS’s average 12-month price target, according to analysts?

Based on analyst ratings, Universal Health’s 12-month average price target is 252.20.

What is UHS’s upside potential, based on the analysts’ average price target?

Universal Health has 9.66% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is UHS a Buy, Sell or Hold?

Universal Health has a consensus rating of Moderate Buy which is based on 3 buy ratings, 2 hold ratings and 0 sell ratings.

What is Universal Health’s price target?

The average price target for Universal Health is 252.20. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $274.00 ,the lowest forecast is $235.00. The average price target represents 9.66% Increase from the current price of $229.98.

What do analysts say about Universal Health?

Universal Health’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 5 Wall Streets Analysts.

How can I buy shares of UHS?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Universal Health (UHS) Stock Forecast & Price Target

UHS Analyst Ratings

UHS Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Universal Health

UHS Analyst Recommendation Trends

UHS Financial Forecast

UHS Earnings Forecast

UHS Sales Forecast

UHS Stock Forecast FAQ

Detailed List of Analyst Forecasts